Advanced glycation end products and cognitive impairment in schizophrenia
Akiko Kobori(Tokyo Metropolitan Institute of Medical Science), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Yasuhiro Miyano(Tokyo Metropolitan Matsuzawa Hospital), Satoshi Usami(Japan Graduate School of Education University), Masanari Itokawa(Fujita Health University), Syudo Yamasaki(The University of Tokyo), Shunya Takizawa(Tokai University), Kazuhiro Suzuki(National Institute of Health Sciences), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Kazuhiro Niizato(Tokyo Metropolitan Matsuzawa Hospital), Akane Yoshikawa(Tokyo Metropolitan Matsuzawa Hospital), Yukihiro Nagase(Takatsuki General Hospital), Yasue Horiuchi(National Taiwan University), Kazuya Toriumi(Tokyo Metropolitan Institute of Medical Science), Kenichi Oshima(Tokyo Metropolitan Matsuzawa Hospital), Atsushi Nishida(Tokyo Institute of Psychiatry), Heii Arai(Tokyo Institute of Psychiatry), Atsushi Imai(Tokyo Metropolitan Matsuzawa Hospital)
Cited by 16
Related Papers
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
|Cell Reports|2018|264
Brain Cannabinoid CB2 Receptor in Schizophrenia
|Biological Psychiatry|2009|184
Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia
|Dementia and Geriatric Cognitive Disorders Extra|2013|173